These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28237373)

  • 1. African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.
    Rajman I; Knapp L; Morgan T; Masimirembwa C
    EBioMedicine; 2017 Mar; 17():67-74. PubMed ID: 28237373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A; Backman JT
    Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study.
    Dodgen TM; Hochfeld WE; Fickl H; Asfaha SM; Durandt C; Rheeder P; Drögemöller BI; Wright GE; Warnich L; Labuschagne CD; van Schalkwyk A; Gaedigk A; Pepper MS
    BMC Med Genet; 2013 Jan; 14():20. PubMed ID: 23356658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 pharmacogenetics in African populations: implications for public health.
    Dandara C; Swart M; Mpeta B; Wonkam A; Masimirembwa C
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):769-85. PubMed ID: 24588448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.
    Matimba A; Del-Favero J; Van Broeckhoven C; Masimirembwa C
    Hum Genomics; 2009 Jan; 3(2):169-90. PubMed ID: 19164093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.
    Solus JF; Arietta BJ; Harris JR; Sexton DP; Steward JQ; McMunn C; Ihrie P; Mehall JM; Edwards TL; Dawson EP
    Pharmacogenomics; 2004 Oct; 5(7):895-931. PubMed ID: 15469410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 pharmacogenetics in African populations.
    Alessandrini M; Asfaha S; Dodgen TM; Warnich L; Pepper MS
    Drug Metab Rev; 2013 May; 45(2):253-75. PubMed ID: 23590174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of drug metabolising enzymes in African populations: implications for the use of neuroleptics and antidepressants.
    Masimirembwa CM; Hasler JA
    Brain Res Bull; 1997; 44(5):561-71. PubMed ID: 9365799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of pharmacogenetic traits in two distinct South African populations.
    Ikediobi O; Aouizerat B; Xiao Y; Gandhi M; Gebhardt S; Warnich L
    Hum Genomics; 2011 May; 5(4):265-82. PubMed ID: 21712189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in Ghana: reviewing the evidence.
    Kudzi W; Adjei GO; Ofori-Adjei D; Dodoo AN
    Ghana Med J; 2011 Jun; 45(2):73-80. PubMed ID: 21857725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
    Kudzi W; Dodoo AN; Mills JJ
    BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review.
    Dorji PW; Tshering G; Na-Bangchang K
    J Clin Pharm Ther; 2019 Aug; 44(4):508-524. PubMed ID: 30980418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
    Staehli Hodel EM; Csajka C; Ariey F; Guidi M; Kabanywanyi AM; Duong S; Decosterd LA; Olliaro P; Beck HP; Genton B
    Antimicrob Agents Chemother; 2013 Feb; 57(2):950-8. PubMed ID: 23229480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP3A5 genotypes and risk of oesophageal cancer in two South African populations.
    Dandara C; Ballo R; Parker MI
    Cancer Lett; 2005 Jul; 225(2):275-82. PubMed ID: 15978331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
    Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
    Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes.
    Makeeva O; Stepanov V; Puzyrev V; Goldstein DB; Grossman I
    Pharmacogenomics; 2008 Jul; 9(7):847-68. PubMed ID: 18597650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population.
    Wright GE; Niehaus DJ; Drögemöller BI; Koen L; Gaedigk A; Warnich L
    Ann Hum Genet; 2010 Jul; 74(4):340-50. PubMed ID: 20597905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.
    Čolić A; Alessandrini M; Pepper MS
    Drug Metab Rev; 2015 May; 47(2):111-23. PubMed ID: 25391641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.